Accuracy of detecting residual disease after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma (preSINO trial): a prospective multicenter diagnostic cohort study.
Zhang X, Eyck BM, Yang Y, Liu J, Chao YK, Hou MM, Hung TM, Pang Q, Yu ZT, Jiang H, Law S, Wong I, Lam KO, van der Wilk BJ, van der Gaast A, Spaander MCW, Valkema R, Lagarde SM, Wijnhoven BPL, van Lanschot JJB, Li Z.
Zhang X, et al. Among authors: liu j.
BMC Cancer. 2020 Mar 6;20(1):194. doi: 10.1186/s12885-020-6669-y.
BMC Cancer. 2020.
PMID: 32143580
Free PMC article.
Clinical Trial.